Stephen Ralston

Stephen Ralston is currently the Chief Commercial Officer at Genesis Research. Prior to this, they were a Partner at SIRIUS Market Access, and before that, the Director of Market Access, Pricing and HEOR at SRHEOR. Stephen has also held positions as Director of Global Health Economics Outcomes Research for Takeda Pharmaceuticals in Europe and Canada, Health Economics Manager for Eli Lilly and Company, and Health Economist for SmithKline Beecham.

Stephen has over 15 years of experience in the field of health economics and outcomes research. Stephen has extensive experience in developing successful strategies and tactics for supporting products in development and bringing them to market. Stephen has also supported affiliates in successful pricing and reimbursement negotiations.

Stephen has a Bachelor of Science in Economics from the University of London.

Stephen Ralston has a Master of Science from the University of York and a Bachelor of Science from the University of Teesside. Stephen studied health economics and economics respectively and graduated in 1998 and 1999.